HIV-1 and HTLV-1 Transmission Modes: Mechanisms and Importance for Virus Spread
Open accessThe DOI matches its Crossref record; 143 of the 144 references it cites were found in a registry or an index; 74 of the 146 sources its claims cite were checked for support.
Abstract
So far, only two retroviruses, human immunodeficiency virus (HIV) (type 1 and 2) and human T-cell lymphotropic virus type 1 (HTLV-1), have been recognized as pathogenic for humans. Both viruses mainly infect CD4+ T lymphocytes. HIV replication induces the apoptosis of CD4 lymphocytes, leading to the development of acquired immunodeficiency syndrome (AIDS). After a long clinical latency period, HTLV-1 can transform lymphocytes, with subsequent uncontrolled proliferation and the manifestation of a disease called adult T-cell leukemia (ATLL). Certain infected patients develop neurological autoimmune disorder called HTLV-1-associated myelopathy, also known as tropical spastic paraparesis (HAM/TSP). Both viruses are transmitted between individuals via blood transfusion, tissue/organ transplantation, breastfeeding, and sexual intercourse. Within the host, these viruses can spread utilizing either cell-free or cell-to-cell modes of transmission. In this review, we discuss the mechanisms and importance of each mode of transmission for the biology of HIV-1 and HTLV-1.
Overview
CoChat Summary
## TL;DR
This review compares how HIV-1 and HTLV-1 spread between cells, emphasizing that HIV-1 can use both cell-free and cell-to-cell transmission, while HTLV-1 relies mainly on cell-to-cell spread. It summarizes the main intercellular structures involved in transmission and argues that understanding them is important for designing transmission-specific antivirals.
## Key findings
- HIV-1 and HTLV-1 are both transmitted by blood transfusion, transplantation, breastfeeding, and sexual intercourse, but within hosts they spread either as free viral particles or by cell-to-cell transfer.
- HTLV-1 is reported to produce very few free virions in vitro, with only 1 out of 10^5–10^6 being infectious, and viral RNA is rarely detected in plasma; by contrast, HIV-1 efficiently uses both transmission modes.
- Quantitative assays summarized in the paper reported that virus-producing cells can be 100–1000 times more infectious than free viral particles, cell-to-cell transmission of HIV-1 can be 18,000 times more efficient than infection with free virions, and cell-to-cell infection was 2-fold higher for HIV-1 and 10,000-fold higher for HTLV-1 than cell-free infection in the authors’ intron-regulated reporter system.
- In one modeling study cited in the review, cell-to-cell transmission was estimated to cause 60% of viral infection, shorten generation time 1.1-fold, and increase viral fitness 3.9-fold; however, the paper notes that later work raised concerns about shaking-culture artifacts.
- For HTLV-1 biofilm-like structures, removal by heparin washing reduced infectious capacity of producing cells by 80%.
## Methods
- This is a narrative review of published work on HIV-1 and HTLV-1 transmission modes, with comparative discussion of entry, assembly, cell-to-cell structures, and in vivo relevance.
- The paper synthesizes evidence from experimental systems including 2D cell culture, 3D cultures, humanized mice, patient materials, microscopy, reporter assays, and mathematical modeling.
- It highlights several assay formats from the literature: shaking-culture assays, β-lactamase reporter assays, virus-like particle assays, and the authors’ intron-regulated reporter vectors (HTLV-1 inLuc/inYFP and HIV-1 inLuc/inYFP).
## Limitations
- The paper states that much of the evidence comes from 2D cell culture, and that it remains unclear which transmission mechanisms are most important in vivo.
- It also states that the detailed mechanisms of viral cell-to-cell transmission are not yet uncovered, and that the importance of specific contact structures for in vitro and in vivo spread remains to be elucidated.
- Evident from the text: the article is a review, so it does not present a single new primary dataset or original comparative experiment of its own.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
55 Valid · 0 Not valid · 42 Not checked · 25 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Recently, we pseudotyped HIV-1 particles with SARS-CoV-2 protein S, and, using the HIV-1 replication-dependent reporter vector, inLuc, demonstrated that the cell-to-cell infection of SARS-CoV-2 was about one order of magnitude less sensitive to neutralization by convalescent sera than cell-free infection.”
§ HIV-1 and HTLV-1 Transmission Modes: Mechanisms and Importance for Virus Spread > 3. Methods for Cell-to-Cell Infectious Transmission Measurement
What the sources say
- Supportedcites [33] Kruglova, N., Siniavin, A., Gushchin, V., and Mazurov, D. (2021). Different Neutralization Sensitivity of SARS-CoV-2 Cell-to-Cell and Cell-Free Modes of Infection to Convalescent Sera. Viruses, 13. source
The Abstract reports that neutralizing activity of convalescent sera was more than tenfold lower in cell cocultures than in cell-free infection. Results §3.1 identifies the SARS-CoV-2 spike-pseudotyped HIV-1 system and its inLuc reporter vector; Methods §2.9 confirms its use in the cell-coculture assay. The paper cautions that this pseudoviral assay does not fully model SARS-CoV-2 transmission, but that does not alter the attributed assay result. (LLM, conf=0.93)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The observed differences were even more pronounced when infection tests were performed using replication-competent coronavirus [33].”
§ HIV-1 and HTLV-1 Transmission Modes: Mechanisms and Importance for Virus Spread > 3. Methods for Cell-to-Cell Infectious Transmission Measurement
What the sources say
- Supportedcites [33] Kruglova, N., Siniavin, A., Gushchin, V., and Mazurov, D. (2021). Different Neutralization Sensitivity of SARS-CoV-2 Cell-to-Cell and Cell-Free Modes of Infection to Convalescent Sera. Viruses, 13. source
Results §3.4 (page unavailable) states that cell-to-cell spread of replication-competent SARS-CoV-2 was almost completely resistant to neutralization by convalescent sera, and that this effect was more pronounced than with pseudoviruses. This directly supports the cited comparison. (LLM, conf=0.95)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“When these vectors were used together with the packaging and Env-encoding plasmids, the reporter signal was only detected in target cells after one cycle of viral replication was completed [30].”
§ HIV-1 and HTLV-1 Transmission Modes: Mechanisms and Importance for Virus Spread > 3. Methods for Cell-to-Cell Infectious Transmission Measurement
What the sources say
- Supportedcites [30] Mazurov, D., Ilinskaya, A., Heidecker, G., Lloyd, P., and Derse, D. (2010). Quantitative comparison of HTLV-1 and HIV-1 cell-to-cell infection with new replication dependent vectors. PLoS Pathog., 6. source
The Results section explains that the intron prevents reporter expression in transfected producer cells, while infection of target cells with particles carrying spliced vector RNA produces a provirus capable of reporter expression. The Figure 1 caption identifies this as single-cycle replication, and the Introduction states that reporter expression is confined to infected target cells. Page numbers are not provided in our copy. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, Chazal et al. reported later that the poor efficiency of HIV-1 replication in the shaking culture of HIV-1-infected T cells was related to the loss of infectivity of cell-free virions produced by shaky lymphocytes [26].”
§ HIV-1 and HTLV-1 Transmission Modes: Mechanisms and Importance for Virus Spread > 3. Methods for Cell-to-Cell Infectious Transmission Measurement
What the sources say
- Supportedcites [26] Chazal, M., Nzounza, P., Pique, C., and Ramirez, B.C. (2014). Loss of infectivity of HIV-1 particles produced by mobile lymphocytes. PLoS ONE, 9. source
The Results section reports that cell-free viruses from shaken T-cell cultures had approximately 10-fold lower infectivity than viruses from static cultures. It says this loss of infectivity, alongside prevention of cell-to-cell transmission, contributes to reduced HIV-1 replication; the Discussion and Conclusion likewise links altered particles to poor replication efficiency. The claim is a fair paraphrase, though loss of cell-free infectivity is not presented as the sole cause. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This analysis showed that the infectivity of purified HTLV-1 VLPs is 1000 times lower than the infectivity of isolated HIV-1 VLPs.”
§ HIV-1 and HTLV-1 Transmission Modes: Mechanisms and Importance for Virus Spread > 3. Methods for Cell-to-Cell Infectious Transmission Measurement
What the sources say
- Partly supportedcites [20] Derse, 2001, Examining human T-lymphotropic virus type 1 infection and replication by cell-free infection with recombinant virus vectors, J. Virol. sourceExperimental — accuracy not yet measured
The Abstract reports that recombinant HTLV-1 virions had at least 1,000-fold lower specific infectivity than analogous HIV-1 particles. The Results and Materials and Methods show that infectivity was tested using filtered supernatants containing recombinant, VSV-G-pseudotyped viruses—not purified HTLV-1 VLPs and isolated HIV-1 VLPs as the claim specifies. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
60 more claims · 21 with their cited sources checked
Create a free account to see all 122 claims and to verify the 28 references still open.
- It may state two separate claims as one. 52
- Probably not a substantial claim. 5
- The quote only partly states this claim. 1
Citations
Cites
DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells
Geijtenbeek, T. B. H., Kwon, D. S., Torensma, R., van Vliet, S. J., van Duijnhoven, G. C. F., Middel, J., Cornelissen, I. L. M. H. A., Nottet, H. S. L. M., KewalRamani, V. N., Littman, D. R., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)80694-7 · Cited by 2,447
Antibody neutralization and escape by HIV-1
Wei, X., Decker, J. M., Wang, S., Hui, H., Kappes, J. C., Wu, X., Salazar-Gonzalez, J. F., Salazar, M. G., Kilby, J. M., Saag, M. S., et al. (2003) · Nature · doi:10.1038/nature01470 · Cited by 2,421 · cited 1×
“Unlike HIV-1 Env, which contains ~25 glycosylation sites [101], and forms a “glycan shield” protecting the virus from neutralizing antibodies [102], HTLV-1 Env contains only five sites for N-glycan attachment [103].”
BackgroundGeijtenbeek, T. B. H., Torensma, R., van Vliet, S. J., van Duijnhoven, G. C. F., Adema, G. J., van Kooyk, Y., & Figdor, C. G. (2000) · Cell · doi:10.1016/s0092-8674(00)80693-5 · Cited by 1,700 · cited 1×
“DC-SIGN was first discovered as a receptor that interacted with ICAM-3 during the formation of contacts between DCs and T cells [75].”
BackgroundSAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx
Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Ségéral, E., Yatim, A., Emiliani, S., Schwartz, O., & Benkirane, M. (2011) · Nature · doi:10.1038/nature10117 · Cited by 1,511 · cited 1×
“For example, sterile alpha motif and HD domain 1 (SAMHD1) inhibits reverse transcription by depleting the cellular pool of deoxynucleotide triphosphates [63,64], and the cytidine deaminase, APOBEC3G, induces hypermutation of the viral genome [65].”
BackgroundHigh frequency retrotransposition in cultured mammalian cells
Moran, J. V., Holmes, S. E., Naas, T. P., DeBerardinis, R. J., Boeke, J. D., & Kazazian, H. H. (1996) · Cell · doi:10.1016/s0092-8674(00)81998-4 · Cited by 1,022 · cited 1×
“This was achieved by adapting a concept developed for the detection of retrotransposition events [31].”
MethodLahouassa, H., Daddacha, W., Hofmann, H., Ayinde, D., Logue, E. C., Dragin, L., Bloch, N., Maudet, C., Bertrand, M., Gramberg, T., et al. (2012) · Nature Immunology · doi:10.1038/ni.2236 · Cited by 852 · cited 1×
“For example, sterile alpha motif and HD domain 1 (SAMHD1) inhibits reverse transcription by depleting the cellular pool of deoxynucleotide triphosphates [63,64], and the cytidine deaminase, APOBEC3G, induces hypermutation of the viral genome [65].”
BackgroundSpread of HTLV-I Between Lymphocytes by Virus-Induced Polarization of the Cytoskeleton
Igakura, T., Stinchcombe, J. C., Goon, P. K. C., Taylor, G. P., Weber, J. N., Griffiths, G. M., Tanaka, Y., Osame, M., & Bangham, C. R. M. (2003) · Science · doi:10.1126/science.1080115 · Cited by 755 · cited 2×
“The VS was first discovered in 2003 in Charles Bangham’s laboratory through confocal microscopy of T lymphocytes obtained from HTLV-1-infected patients co-cultured with T lymphocytes isolated from healthy donors [34].”
BackgroundSowinski, S., Jolly, C., Berninghausen, O., Purbhoo, M. A., Chauveau, A., Köhler, K., Oddos, S., Eissmann, P., Brodsky, F. M., Hopkins, C., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1682 · Cited by 754 · cited 1×
“TNTs have a diameter of less than 200 nm and a length of about 22 μm, making them 5–10 times longer than filopodia [108].”
BackgroundRecruitment of HIV and Its Receptors to Dendritic Cell-T Cell Junctions
McDonald, D., Wu, L., Bohks, S. M., KewalRamani, V. N., Unutmaz, D., & Hope, T. J. (2003) · Science · doi:10.1126/science.1084238 · Cited by 707 · cited 1×
“Within a few minutes after the formation of the cell conjugates, the accumulation of CD4, CCR5, CXCR4, and HIV-1 was observed at the intercellular contact sites, and the captured HIV-1 particles were located on or near the MDDC surface [89].”
BackgroundHuman T-lymphotropic virus 1: recent knowledge about an ancient infection
Verdonck, K., González, E., Van Dooren, S., Vandamme, A.-M., Vanham, G., & Gotuzzo, E. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70081-6 · Cited by 661 · cited 1×
“The capsid core contains two copies of positive single strand genomic RNA (gRNA) in complex with the nucleocapsid protein (NC) and replication enzymes reverse transcriptase (RT) and integrase (IN) [1,2] (Figure 1).”
Background
Cited by
Masenga, S. K., Mweene, B. C., Luwaya, E. L., Muchaili, L., Chona, M., & Kirabo, A. (2023) · Cells · doi:10.3390/cells12101351 · Cited by 142
Polysaccharides and Their Derivatives as Potential Antiviral Molecules
Claus-Desbonnet, H., Nikly, E., Nalbantova, V., Karcheva-Bahchevanska, D. P., Ivanova, S., Pierre, G., Benbassat, N., Katsarov, P., Michaud, P., Lukova, P., et al. (2022) · Viruses · doi:10.3390/v14020426 · Cited by 101
Martínez-Mármol, R., Giordano-Santini, R., Kaulich, E., Cho, A.-N., Przybyla, M., Riyadh, M. A., Robinson, E., Chew, K. Y., Amor, R., Meunier, F. A., et al. (2023) · Science Advances · doi:10.1126/sciadv.adg2248 · Cited by 94
“Cell-to-cell contact has been shown to be involved in the spreading of HIV ( 14 ), measles ( 51 ), and SARS-CoV-2 ( 57 ), but viral-mediated neuronal fusion remained poorly understood.”
Current status of mannose receptor-targeted drug delivery for improved anti-HIV therapy
Rojekar, S. V., Gholap, A. D., Togre, N. S., Bhoj, P. S., Haeck, C. M., Hatvate, N. T., Singh, N., Vitore, J. G., Dhoble, S., Kashid, S., et al. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.06.002 · Cited by 47
Apetroaei, M.-M., Velescu, B. Ș., Nedea, M. I., Dinu‐Pîrvu, C. E., Drăgănescu, D., Fâcă, A. I., Udeanu, D. I., & Arsene, A. L. (2024) · Biomedicines · doi:10.3390/biomedicines12040915 · Cited by 45
“The envelope is composed of a combination of viral and host cell proteins [15,16].”
BackgroundHTLV‐1 persistent infection and ATLL oncogenesis
Zuo, X., Zhou, R., Yang, S., & Ma, G. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28424 · Cited by 39
Nakahata, S., Enríquez, D., Jahan, M. I., Sugata, K., & Satou, Y. (2023) · Biomolecules · doi:10.3390/biom13101543 · Cited by 38
“…genes, such as HIV-1 transactivator of transcription (Tat) and Rev of HIV; Tax and Rex of HTLV-1; accessory genes such as Vif, Vpr, Vpx, Vpu, and Nef of HIV; p12, p13, p30, and the HTLV-1 bZIP factor (HBZ) of HTLV-1, which are flanked by 5 (cid:48) and 3 (cid:48) long terminal repeats (LTR) [15].”
BackgroundInterplay between endogenous and exogenous human retroviruses
Kyriakou, E., & Magiorkinis, G. (2023) · Trends in Microbiology · doi:10.1016/j.tim.2023.03.008 · Cited by 30
Progress and Recent Developments in HIV Vaccine Research
Shim, I., Rogowski, L., & Venketaraman, V. (2025) · Vaccines · doi:10.3390/vaccines13070690 · Cited by 28
“HIV specifically targets CD4 + T lymphocytes, which secrete cytokines that activate other immune cells such as macrophages and dendritic cells [6,7].”
InfluentialSantana, C. S., Andrade, F. D. O., da Silva, G. C. S., Nascimento, J. O. D. S., Campos, R. F., Giovanetti, M., Santos, L. A., Gois, L. L., Alcantara, L. C. J., & Barreto, F. K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1073779 · Cited by 23
Xiao, Q., Liu, Y., Shu, X., Li, Y., Zhang, X., Wang, C., He, S., Li, J., Li, T., Liu, T., et al. (2025) · Experimental Hematology and Oncology · doi:10.1186/s40164-025-00655-2 · Cited by 23
“Additionally, HBZ (HTLV-1 bZIP factor) is expressed from the antisense strand and contributes to viral persistence and pathogenesis by modulating host gene expression and T-cell proliferation [116].”
The Past, Present, and Future of a Human T-Cell Leukemia Virus Type 1 Vaccine
Tu, J. J., Maksimova, V. V., Ratner, L., & Panfil, A. R. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.897346 · Cited by 18
“Unlike many other viruses, cell-free infection by HTLV-1 is extremely inefficient (although HTLV-1 infected cells do produce low titers of detectable virus) (Mazurov et al., 2010; Kalinichenko et al., 2022).”
BackgroundGhezeldasht, S. A., Mosavat, A., & Rezaee, S. A. (2024) · Reviews in Medical Virology · doi:10.1002/rmv.2567 · Cited by 12
“99 Moreover, DC ‐ SIGN facilitates temporary adhesion between DCs and T lymphocytes by binding to ICAM ‐ 3, a protein found on T cells.”
Dou, A., Xu, J., & Zhou, C. (2025) · Virulence · doi:10.1080/21505594.2025.2523888 · Cited by 11
Tuning Rex rules HTLV-1 pathogenesis
Nakano, K., & Watanabe, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.959962 · Cited by 12
Buck, A. M., Deveau, T., Henrich, T. J., & Deitchman, A. N. (2023) · Viruses · doi:10.3390/v15051126 · Cited by 11
Oncoviral Infections and Small Extracellular Vesicles
Ważny, Ł., Whiteside, T. L., & Pietrowska, M. (2024) · Viruses · doi:10.3390/v16081291 · Cited by 6
“The virus spreads 10,000 times more effectively this way compared to the release of free virions [122].”
BackgroundViral Oncogenesis: Synergistic Role of Genome Integration and Persistence
Frazia, S. L., Pauciullo, S., Zulian, V., & Garbuglia, A. R. (2024) · Viruses · doi:10.3390/v16121965 · Cited by 15
“The proviral DNA of HTLV-1 obtained by reverse transcription, as in HIV, has two long terminal repeat (LTR) sequences at its ends [161,162].”
InfluentialDevelopment of nanobiosensors for human immunodeficiency virus detection—a mini review
Mudenkattil, S., Girigoswami, A., Jayaprakash, T., & Girigoswami, K. (2022) · Exploration of Medicine · doi:10.37349/emed.2022.00109 · Cited by 9
Unraveling the role of ZNF506 as a human PBS-pro-targeting protein for ERVP repression
Wu, Q., Fang, L., Wang, Y., & Yang, P. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad731 · Cited by 8
Almaw, A., Assefa, A., Berhan, A., et al. (2024) · Health Science Reports · doi:10.1002/hsr2.70056 · Cited by 6
Mazurov, D. V., & Herschhorn, A. (2023) · mBio · doi:10.1128/mbio.02428-23 · Cited by 5
Self-citationBrites, C. R., Tonto, P. B., Vallinoto, A. C. R., Oliveira, O. D. S., Simionatto, S., Bay, M. B., Reuter, T. Q., da Silva, M. M. G., Medeiros, M. S., Mayoral, R., et al. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1511374 · Cited by 7
Human T-cell leukemia virus type 1: oncogenic potential and vaccine development strategies
Vásconez-González, J., Suárez-Sangucho, I. A., Acosta-Muñoz, E., y Miño, L. P., Borja-Mendoza, D. A., Alexander-Castillo, J. A., Saa, J., Salazar-Calvopiña, N., Cárdenas, P., López‐Cortés, A., et al. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1587802 · Cited by 4
Kawano, K., Hashikura, Y., & Umekita, K. (2024) · Viruses · doi:10.3390/v16020249 · Cited by 4
“The Gag protein is composed of the matrix protein p19, the capsid protein p24, and the nucleocapsid p15 [14].”
BackgroundGlobal co-dynamics of viral infections with saturated incidence
Elaiw, A. M., Alsaadi, G. S., & Hobiny, A. D. (2024) · AIMS Mathematics · doi:10.3934/math.2024671 · Cited by 6
Assess the Knowledge of Medical Students About HTLV-1 in Mashhad University of Medical Science
Rafatpanah, H., Jarahi, L., Mahmoudabadi, M., Sarbaz, M., Baigi, S. F. M., & Kimiafar, K. (2022) · Frontiers in Health Informatics · doi:10.30699/fhi.v11i1.394 · Cited by 5
Double Trouble Co-Infections: Understanding the Correlation Between COVID-19 and HIV Viruses
Abbasi, S. A. A., Noor, T., Mylavarapu, M., SAHOTRA, M., Bashir, H. A., Bhat, R. R., Jindal, U., Amin, U., Anushree, V., & Siddiqui, H. F. (2023) · Cureus · doi:10.7759/cureus.38678 · Cited by 3
Dinakarkumar, Y., Ramakrishnan, G., Ramaiah, M. J., Reddy, M. M., John, R. M., Raj, A. L. T., & Chamarthy, S. (2025) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2025.100215 · Cited by 3
Prevalence and genetic diversity of HTLV-1 among blood donors in Jiroft, Iran: a comprehensive study
Edalat, F., Gholamzad, A., Ghoreshi, Z., et al. (2025) · Virus Genes · doi:10.1007/s11262-025-02159-x · Cited by 2
“Infected cells in the mother’s milk can directly infect the infant’s immune cells, leading to vertical transmission [4].”
InfluentialReda, O., & Satou, Y. (2026) · Viruses · doi:10.3390/v18010140 · Cited by 2
“A comparative review of HTLV-1 and HIV-1 transmission modes and their impact on virus spread is provided in [30].”
Ghezeldasht, S. A., Bidkhori, H. R., Miri, R., Baghban, A., Mosavat, A., & Rezaee, S. A. (2023) · Journal of NeuroVirology · doi:10.1007/s13365-023-01160-0 · Cited by 2
A novel hybrid method with convergence analysis for approximation of HTLV-I dynamics model
Molavi‐Arabshahi, M., Rashidinia, J., & Yousefi, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-76110-9 · Cited by 2
“It can be transmitted through various bodily fluids, including breast milk, semen, and blood 4 .”
BackgroundNeutrophil-lymphocyte ratio as an indicator of recovery phase in children with dengue fever
Pribadi, M. I., Umma, H. A., & Siregar, R. (2025) · Trends in Pediatrics · doi:10.59213/tp.2025.199 · Cited by 1
Cuenca, N., Cordero, D., & López‐Ulloa, B. (2025) · Pathogens · doi:10.3390/pathogens14050470 · Cited by 1
“Predisposition to the mentioned diseases depends on the immunogenetic profile of the host since the interaction between the virus and the immune response plays a key role in the development [11].”
Garma-Solis, I. J., Zapata-Arceo, F. S., Ayuso-Diaz, V. M., et al. (2025) · Cureus · doi:10.7759/cureus.88163 · Cited by 1
“…most of these findings originate from experimental and in vitro models, limited patient-based evidence indicates that comparable mechanisms may be present in vivo in individuals with HTLV-1-associated diseases, including HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) [2,4].”
A review of the literature: Tuberculosis among HTLV-1-infected individuals in Latin America
Nakazaki, J. C. F., Cotera-Ramón, A. I., Medina, R. G., & Henostroza, G. (2026) · Journal of Investigative Medicine · doi:10.1177/10815589261422248 · Cited by 1
Cytotoxic and viricidal effects of human semen on mumps virus‐infected lymphocytes: In vitro studies
Wang, F., Shao, X., Bao, B., et al. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29733 · Cited by 1
“19 However, the potential effects of SP on cell ‐ mediated viral infection and sexual transmission have yet to be investigated.”
BackgroundSoltani, S., Mozhgani, S., Roohinezhad, R., Emami, S. H., Emami, M. H., Solooki, S., Hesari, M. F., Doroozeh, N., & Norouzi, M. (2024) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2024.0010 · Cited by 1
Rodríguez-López, E. R., López, P. L., Rodríguez, Y., Sánchez, R., Acevedo, V.-S., Encarnación-Medina, J., Tirado, G., Ortíz, C., Mésplède, T., & Rivera‐Amill, V. (2024) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2023.0128 · Cited by 1
“18,40,58,59 62 Drug-resistance mutations and polymorphisms have been shown to alter the ability of the viral particle to perform mechanisms such as viral infectivity or integration.”
Hosseini, P., Foroushani, A. R., Marjani, A., Tavakoli, M., Amiri, A., Hosseini, A., Bahavar, A., Mozhgani, S., & Norouzi, M. (2023) · Iranian Journal of Microbiology · doi:10.18502/ijm.v15i3.12910 · Cited by 2
“HTLV-1 is transmitted in various routes such as blood transfusion, intravenous injection, sexual contact, vertical transmission from mother to baby, breastfeeding, and organ transplant (8, 9).”
Lymphoma: Potential Viral Antagonism between HTLV-1 and JCV Associated with Increased Survival TimePreprint
Tomasović, A. (2024) · Qeios · doi:10.32388/n2xizz
Itabashi, K., Miyazawa, T., Nakashima, M., Makiyama, J., & Uchimaru, K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15717-2.00051-2
Lymphoma: Potential Viral Antagonism between HTLV-1 and JCV Associated with Increased Survival TimePreprint
Tomasović, A. (2024) · Qeios · doi:10.32388/n2xizz.2
Lazzeri, C., Grossi, P., Precisi, A., Rossolini, G. M., Cusi, M. G., Pane, P. L., Bagatti, S., Santini, L. E., & Peris, A. (2024) · Transplant Infectious Disease · doi:10.1111/tid.14293
Kubheka, T. I. (2024) · ResearchSpace (University of KwaZulu-Natal) · doi:10.29086/10413/23007
Viral Infections and Different Cancers
Abbas, S., & Perveen, S. (2024) · Springer eBooks · doi:10.1007/978-981-97-6948-3_4
History of the human viral infection and their clinical manifestation
Karkhur, Y., Upadhyay, A., & Kumar, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-15283-2.00001-4 · Cited by 3
Collia-Acosta, V. E., García-Tovar, C. G., Quintero‐Ramírez, V., et al. (2025) · CellBio · doi:10.4236/cellbio.2025.141001
Direct Intercellular Transport Mode of Filovirus Nucleocapsids
Ibrahim, C. H. O., & Takamatsu, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178485 · Cited by 2
T Cell Dysfunction in HIV Infection and Its Therapeutic Prospects
王, 宣. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.15103003
Highly efficient production of HIV-1 AD8 gp120 in mammalian cells
Mathur, T., Ahmed, S., Parthasarathy, D., & Herschhorn, A. (2025) · Journal of Virology · doi:10.1128/jvi.01359-25
Quintremil, S., Valenzuela, M. A., Rivera, M., Pando, M. E., Reyes, J., Vásquez, C., Ramírez, E., V, Utreras, E., & Puente, J. (2025) · AIDS Research and Human Retroviruses · doi:10.1177/08892229251394667 · Cited by 1
“98,99 In brain samples of these patients the high CRMP-2-pSer 522 levels were associated with CDK5/p25 hyperactivation.”
Transcriptomic and Epitranscriptomic Landscape of Integrated HTLV-1 in MT2 Cells
Wei, S., Zhang, B., Han, J., Li, H., Liu, Y., Jia, L., Li, J., Huang, X., & Li, L. (2025) · Viruses · doi:10.3390/v18010057 · Cited by 2
“HTLV-1-infected T cells have been shown to produce very few free virions in vitro, indicating that progeny RNA had a negligible contribution to the epitranscriptomic dataset [37].”
Shen, L., Wang, F., Lei, C., Zhang, X., & Zhang, Y. (2026) · Journal of Molecular Histology · doi:10.1007/s10735-025-10687-x
Manriquez, A. H., Kishan, A., Khela, H. S., et al. (2026) · Spine Open · doi:10.1097/bn9.0000000000000052
Modulation de la fonctionnalité des cellules dendritiques humaines par le rétrovirus HTLV-1
Carcone, A. (2023) · theses.fr (ABES) · doi:10.70675/7c8dfa21z0138z4187zb4e3z1e6596bfbedc
Huang, T., Mu, Y., Wu, X., et al. (2026) · AIDS Research and Therapy · doi:10.1186/s12981-026-00870-9
The challenge of HTLV-1 therapeutics: lessons from anti-protease approaches
Ghezeldasht, S. A., Miri, R., Shamsian, S. K., Mosavat, A., & Rezaee, S. A. (2026) · New Microbes and New Infections · doi:10.1016/j.nmni.2026.101776
“Unlike HIV-1, where protease and polymerase are encoded by a shared reading frame [6], HTLV-1 PR is encoded by a specific reading frame in the HTLV-1 genome.”
Neto, G. D. S. P., Alves, A. C. V., Botelho, B. J. S., da Silva, A. S., Carneiro, D. M., Burbano, R. M. R., Ishak, R., Vallinoto, A. C. R., & Vallinoto, I. M. V. C. (2026) · Journal of Medical Virology · doi:10.1002/jmv.71024
“HTLV‐1 exhibits tropism for CD4 + T lymphocytes and is the causative agent of a neoplasm of CD4 + and CD25 + T cells, known as adult T‐cell leukemia/lymphoma (ATLL), that is classified according to its pathogenicity into: latent, chronic, acute, and lymphoma [12, 13].”
Bomfim, M. A., Bezerra-Neto, J. P., Silva, L. B. D. M., da Silva, M. G. B., Galisa, S. L. G., de Oliveira, N. M., Teixeira, V. G. D. S., Brito, J. A. D., Loureiro, P. R. A. D. C., Sena, G. R., et al. (2026) · Brazilian Archives of Biology and Technology · doi:10.1590/1678-4324-2026250599
Aliyu, V. A., Akinsulie, O. C., Olowu, B. I., Idris, I., Ajibade, F. A., Babawale, P. I., Adebowale, O. O., Ugwu, C. E., Ukauwa, C. B., Itumo, O. E., et al. (2026) · Pathogens · doi:10.3390/pathogens15080800
“Unlike many other retroviruses, HTLV-1 propagates primarily through cell-to-cell contact rather than the release of free virions, driving the clonal expansion of infected host cells [89].”
Development of Imaging Techniques for HIV-1 Cell-Cell Contacts and T-cells
Aguilar, R. S. (2025) · Digital Commons - DU (University of Denver) · doi:10.56902/etdcrp.2025.97
Abyar, S., Mohebbi, S. R., Hosseini, S. M., et al. (2026) · Journal of Medical Virology · doi:10.1002/jmv.71107
Alwaseah, N. S., Binjomah, A. Z., Saleem, R. A., Sajid, M. R., Tamim, H., Imtiaz, M., & Majid, A. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15187058
“HTLV I/II is transmitted through sexual contact, breastfeeding, and blood transfusion, and remains endemic in parts of Africa, South America, and Japan [24,47].”
Cutting-edge developments in computer-aided anti-HIV drug design
Yang, W., Wang, Y., Feng, C., Tang, W., & Sun, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1873962
Chervyakova, Y. V., Smirnova, A. V., Siniavin, A. E., Soldatova, V. E., Gamzik, D. D., Tvorogova, A. V., Мухарбекович, Н. И., Filatov, A. V., Kruglova, N. A., & Maslennikova, A. (2026) · Cells · doi:10.3390/cells15181704 · Cited by 1
Metadata
- Authors
- Kalinichenko, S., Komkov, D., & Mazurov, D.
- Affiliations
- Cell and Gene Technology Group, Institute of Gene Biology RAS, 119334 Moscow, Russia
- Institute of Gene Biology (RU)
- Corresponding author
- Mazurov, Dmitriy
- Venue
- Viruses
- Publisher
- MDPI AG
- Published
- 2022-01-14
- Volume
- 14
- Issue
- 1
- Pages
- 152
- ISSN
- 1999-4915 (ISSN-L)
- PMC
- PMC8779814
- OpenAlex
- W4205791358
- Semantic Scholar
- 95be7a033200fee7fe10a3f6ee57346ed08cbdbb
- Cited by
- 68
- References
- 144
- Citations by year
- 2026: 13 · 2025: 18 · 2024: 18 · 2023: 13 · 2022: 6
- FWCI
- 1.39
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Viruses (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Ministry of Science and Higher Education of Russia (075-15-2019-1661)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Keywords
- HIV-1, HTLV-1, retrovirus transmission, cell-to-cell transmission, blood transfusion, breastfeeding, sexual transmission, apoptosis, adult T-cell leukemia/lymphoma, tropical spastic paraparesis, viral pathogenesis
- MeSH terms
- Animals, Humans, Human T-lymphotropic virus 1, Leukemia-Lymphoma, Adult T-Cell, HTLV-I Infections, CD4-Positive T-Lymphocytes, HIV-1, HIV Infections, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.